CAS RN: 45170-31-8
N-(tert-Butoxycarbonyl)-N-methyl-L-valine
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260128 |
1g / 5g / 25g / 100g / 500g |
Confirm by inquiry |
Shandong, Shanghai | 5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 5g, 25g, 10g, 1g, 100g, 500g
- Available purity: ≥98%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 45170-31-8
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 5g |
≥98% |
5
In Stock
|
Beijing |
Inquiry |
| 25g |
≥98% |
5
In Stock
|
Beijing |
Inquiry |
| 10g |
≥98% |
3
In Stock
|
Beijing |
Inquiry |
| 1g |
≥98% |
1
In Stock
|
Shanghai |
Inquiry |
| 100g |
≥98% |
0
Out of Stock
|
Beijing |
Inquiry |
| 500g |
≥98% |
0
Out of Stock
|
Hong Kong |
Inquiry |
45170-31-8 / 3-methyl-2-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]butanoic acid
Standard CAS: 45170-31-8
Multi CAS: Yes
Basic Information
CAS
45170-31-8
Multi CAS
Yes
Molecular Formula
C11H21NO4
Molecular Weight
231.290000
Exact Mass
231.147058
InChI
InChI=1S/C11H21NO4/c1-7(2)8(9(13)14)12(6)10(15)16-11(3,4)5/h7-8H,1-6H3,(H,13,14)
InChIKey
XPUAXAVJMJDPDH-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
16
Fraction Csp3
0.82
Rotatable bonds
3
H-bond acceptors
3
H-bond donors
1
Molar refractivity
60.26
TPSA
66.84
LogP / Solubility
WLOGP
1.96
MLOGP
1.73
XLogP3
2.1
Consensus LogP
1.93
Log S (ESOL)
-2.31
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.87
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-3.15
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.74
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2